Shukla speaks to Isro chairman, experiments reviewed
Shubhanshu Shukla
, currently aboard the International Space Station (ISS) as part of the Axiom-4 (Ax-4) mission, spoke with Isro chairman V Narayanan on July 6, 2025,
Isro
said Monday.
The telephonic conversation focused on Shukla's health, mission progress, and the scientific work being undertaken in orbit.
'The chairman inquired about the experiments being conducted and emphasised the importance of detailed documentation post-mission. He noted that the observations and outcomes from this mission would provide critical inputs for India's upcoming human spaceflight mission, Gaganyaan,' Isro said
Senior Isro officials also joined the discussion, including VSSC director S Unnikrishnan Nair, M Mohan, director, LPSC, Padmakumar ES, director, Isro Inertial Systems Unit, M Ganesh Pillai, scientific secretary, Isro and N Vedachalam, former director of LPSC.
The officials interacted with Shukla and discussed various aspects of the experiments. Shukla, who has been conducting several scientific studies aboard the ISS under the Isro–Axiom Spaceflight agreement, shared updates on the objectives and challenges of the research.
Narayanan reaffirmed that Isro continues to provide mission support and recalled his prior meetings with Shukla to guide and motivate him before the launch. He also noted regular interactions with standby astronaut Prashant Balan Nair to ensure mission readiness.
Shukla's observations and inputs are expected to contribute significantly to the
Gaganyaan mission
, which aims to demonstrate India's ability to send astronauts into low Earth orbit and return them safely.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
3 hours ago
- The Hindu
Quick fix: on India's Research Development and Innovation scheme
The Union Cabinet recently approved a ₹1-lakh crore Research Development and Innovation (RDI) scheme that aims to incentivise the private sector to invest in basic research. The scheme will primarily consist of a special purpose fund established within the Anusandhan National Research Foundation (ANRF), which will act as the custodian of funds. The funds will be in the form of low-interest loans. The ANRF is conceived as an independent institutional body, with oversight by the Science Ministry, to allocate funds for basic research and to incentivise private sector participation in core research. The involvement of the ANRF here is a novel move as the newly created organisation is meant to be the equivalent of a single-window clearance mechanism for funding research and development for universities and academic institutions. It is also expected to get about 70% of its budget from private sources. In sum, through the RDI and the ANRF, the government is looking to stake the bold claim that it has played its part and that it is now up to the private sector to come forward and reverse the ratio from where the government today accounts for about 70% of India's R&D spend. However, already incipient in the government's tall ambitions are traces of what has caused previous such schemes to falter. The first of these is conservatism. It turns out that a condition for availing funds is that only products that have reached a certain level of development and market potential or, what are called Technology Readiness Level-4 (TRL-4) projects, would be eligible. There are nine TRL levels, a hierarchy that was first conceived by the United States' National Aeronautics and Space Administration (NASA) in the 1970s. TRL-1 represents a basic level of research and TRL-9 a state of advanced readiness. TRL-4 appears to be an arbitrary decision to support any promising research that has progressed halfway. Were there such a magic sauce, venture capital industries, premised on the fickleness of predicting the 'next big thing', would not exist. The scheme also seems to forget that technologically advanced countries have become what they are because of their military industrial complexes — where the spectre of war incentivises the development of technology that is risky and expensive but, over time, may prove to be of immense civilian value — examples are the Internet or the Global Positioning System. India continues to haemorrhage scientists to the West due to the lack of opportunities commensurate with their training. Finally, it lacks a deeply skilled manufacturing sector that can make the products that scientists conceive of. Budgetary allowances cannot overnight fix that which requires major surgery.
Time of India
3 hours ago
- Time of India
Gujarat scientist in US Developing Tech for effective treatment of brain diseases
Vadodara: A Gujarati scientist, native of Vadodara, is working on a technology that would deliver drugs in a larger quantity inside the brain. Dr Ishan Shah is a key member of the US team that has already got intellectual property (IP) rights for the research. "It's a long process, but this technology will help those suffering from any kind of brain diseases. Currently, only 0.1% of any drug given for brain ailments is able to enter the brain. It is a challenge to deliver the drugs inside the brain, which blocks a major quantity," explained Shah, who works for a private biotech company in Boston. "We are developing antibodies that will increase the quantity of drugs delivered inside the brain from 0.1% to 1%. This will increase the efficacy of drugs. We discovered a protein that captures the drug and puts it inside the brain. Our firm even got IP rights. Such an experiment is being undertaken for the first time," Shah told TOI over the phone from the US. The team's work has also been published by the Royal Society of Chemistry. Shah, 38, was also a member of the team working on an effective drug for Alzheimer's, which currently has no cure. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Launch by L&T – 3 & 4 BHKs Near Viviana L&T Evara Heights Enquire Now Undo "We are trying to find out the reason behind the spike of a certain protein that causes Alzheimer's. If we manage to ascertain the reason and control the accumulation of this protein, we will be able to delay the advancement of Alzheimer's. The drug is already in the trial stage," Shah, a senior scientist, added. He is the only Indian in the team working on this drug. A student of Bright School in Karelibaug, Shah completed his Bachelor's in Pharmacy from A R College of Pharmacy in Vidyanagar in 2009. He then pursued a Master's in Pharmacy at the University of Toledo in Ohio. "I wanted to stay in the field of drug discovery, so I pursued a PhD in pharmaceutical chemistry from the University of Kansas in 2011. Then I shifted to Boston, where I worked with a small firm before joining my current company in 2020," said Shah, who is settled in Boston with his wife, Kinjal.
Time of India
4 hours ago
- Time of India
Ax-4 enters final leg, aboard space station, return any day after July 9
BENGALURU: The Axiom-4 mission (Ax-4) crew, including Indian astronaut Shubhanshu Shukla (Shux), has entered the final stretch of their time aboard the International Space Station (ISS), with their return to Earth anticipated any day after July 9. As of July 8, the crew has completed 13 days in orbit as part of the mission that was planned to last up to 14 days aboard the orbiting lab. While no formal announcement has been made about the undocking schedule, preparations are likely under way for the complex coordination required to bring the team safely back. Returning from space is no simple affair. Multiple factors — including weather at the landing site, spacecraft readiness, and alignment with other station and orbital schedules — must align precisely. Ground teams from Axiom Space, SpaceX , Nasa , and international partners will be monitoring all parameters closely before giving the final 'go' for re-entry. Meanwhile, science has continued uninterrupted. Mission pilot Shux has remained at the centre of several key experiments. Over the past few days, Shux examined cyanobacteria — a type of photosynthetic bacteria that can produce their own food using sunlight — under different conditions aboard the ISS. By comparing strains, scientists hope to understand how spaceflight alters the growth and function of these photosynthetic bacteria. He continued with his muscle loss (myogenesis) study and conducted a microscopy session and collected cell samples to investigate how microgravity accelerates muscle loss, a critical issue for long-duration missions. In another experiment, he deployed culture bags for the 'Space Microalgae' study. These tiny organisms, with their ability to produce food, oxygen, and even biofuels, are being studied as potential life-support tools for future interplanetary journeys. His work extended to redeploying components of the 'Voyager Displays' experiment, focused on how space affects gaze coordination and pointing accuracy — vital for designing future spacecraft interfaces. The rest of the Ax-4 crew has also kept up a packed research schedule. Commander Peggy Whitson has been supporting and guiding the team with her decades of space experience. Among other projects, the crew continued working on the PhotonGrav study, collecting brain activity data using near-infrared spectroscopy. This is part of a broader effort to develop neuroadaptive technologies that could help astronauts interact more intuitively with onboard systems — and could eventually benefit people on Earth with neurological or motor impairments. Mission Specialist Tibor Kapu completed work on 'VITAPRIC', nurturing radish and wheat microgreens that may one day provide astronauts with fresh produce on long-duration missions. He also continued with the 'Fruit Fly DNA Repair' study, which tracks how radiation in space affects genetic material — key for developing safeguards for future human missions beyond low Earth orbit. The crew has participated in several more studies: from the Wireless Acoustics experiment to evaluate wearable sound monitors, to the 'Acquired Equivalence Test' that probes cognitive function in weightlessness. Data has been collected for cardiovascular and balance system changes under the 'Telemetric Health AI' project, aimed at advancing real-time health tracking. As Earth awaits their return, the Ax-4 astronauts remain focused. Each hour in orbit is still being put to use — ensuring that when they do return, they bring back not just stories and photographs, but data that may aid in shaping the future of human spaceflight.
